Darifenacin
Pricing Report NDC 0591-4380-19

Latest NADAC: $3.98905 per EA · Effective Jul 17, 2019 · Est. package price $359.01 (90 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Darifenacin (NDC 0591-4380-19) is $3.98905 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 17, 2019.

As a provided by Actavis Pharma, Inc., this medication is distributed in a 90 TABLET, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$3.98905
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jul 17, 2019
Billable Units
90 EA
Estimated Package Price
$359.01
Data Status
As of Jul 31, 2019
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0591-4380-19
Description
90 TABLET, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2016, the NADAC wholesale price for (NDC ) has moved within a range of $0.81392 to $8.50045 per EA. Over this 4 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.8139 - $8.5005
Market Volatility
944.38% Variance
Latest Trend
53.59%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Apr 21, 2021 $0.81392 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 21, 2021 $0.81392 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Mar 17, 2021 $1.75367 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 17, 2021 $2.11930 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 20, 2021 $2.35824 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 23, 2020 $2.40167 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 18, 2020 $2.46500 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 21, 2020 $2.61730 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 23, 2020 $2.33593 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 19, 2020 $2.96405 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 22, 2020 $1.89543 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 17, 2020 $2.44854 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026